Transamerica Financial Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $388K | Buy |
3,755
+1,295
| +53% | +$116K | 0.03% | 321 |
|
|
2026
Q1 | $177K | Buy |
2,460
+1,566
| +175% | +$121K | 0.02% | 412 |
|
|
2025
Q4 | $71K | Buy |
894
+476
| +114% | +$37.5K | 0.01% | 497 |
|
|
2025
Q3 | $31.5K | Buy |
418
+415
| +13,833% | +$28.4K | ﹤0.01% | 538 |
|
|
2025
Q2 | $172 | Sell |
3
-17
| -85% | -$1.11K | ﹤0.01% | 508 |
|
|
2025
Q1 | $2K | Sell |
20
-24
| -55% | -$1.44K | ﹤0.01% | 394 |
|
|
2024
Q4 | $2K | Sell |
44
-26
| -37% | -$1.46K | ﹤0.01% | 386 |
|
|
2024
Q3 | $5K | Sell |
70
-14,906
| -100% | -$870K | ﹤0.01% | 351 |
|
|
2024
Q2 | $885K | Hold |
14,976
| – | – | 0.09% | 146 |
|
|
2024
Q1 | $1.2M | Buy |
14,976
+2,301
| +18% | +$176K | 0.12% | 138 |
|
|
2023
Q4 | $1M | Sell |
12,675
-5,575
| -31% | -$397K | 0.14% | 105 |
|
|
2023
Q3 | $1.27M | Sell |
18,250
-882
| -5% | -$62.5K | 0.17% | 107 |
|
|
2023
Q2 | $1.32M | Buy |
19,132
+5,419
| +40% | +$386K | 0.17% | 108 |
|
|
2023
Q1 | $1.02M | Buy |
13,713
+3,941
| +40% | +$330K | 0.13% | 128 |
|
|
2022
Q4 | $911K | Buy |
9,772
+1,207
| +14% | +$116K | 0.13% | 144 |
|
|
2022
Q3 | $817K | Buy |
8,565
+8,564
| +856,400% | +$848K | 0.12% | 134 |
|
|
2022
Q2 | $1K | Buy |
+1
| New | +$98 | ﹤0.01% | 438 |
|
|
2020
Q3 | – | Sell |
-42
| Closed | -$3K | – | 228 |
|
|
2020
Q2 | $3K | Buy |
42
+34
| +425% | +$2.14K | ﹤0.01% | 299 |
|
|
2020
Q1 | $1K | Buy |
+8
| New | +$534 | 0.02% | 71 |
|
|
2019
Q3 | – | Sell |
-286
| Closed | -$16K | – | 169 |
|
|
2019
Q2 | $16K | Buy |
+286
| New | +$15.4K | ﹤0.01% | 280 |
|
|
2019
Q1 | – | Sell |
-400
| Closed | -$27K | – | 158 |
|
|
2018
Q4 | $27K | Buy |
400
+37
| +10% | +$2.76K | 0.01% | 255 |
|
|
2018
Q3 | $29K | Buy |
363
+354
| +3,933% | +$25.3K | 0.01% | 255 |
|
|
2018
Q2 | $1K | Buy |
+9
| New | +$593 | ﹤0.01% | 355 |
|
|
2016
Q2 | – | Sell |
-3,151
| Closed | -$327K | – | 456 |
|
|
2016
Q1 | $327K | Buy |
3,151
+2,550
| +424% | +$248K | 0.03% | 266 |
|
|
2015
Q4 | $59K | Hold |
601
| – | – | ﹤0.01% | 384 |
|
|
2015
Q3 | $58K | Hold |
601
| – | – | ﹤0.01% | 368 |
|
|
2015
Q2 | $63K | Buy |
601
+100
| +20% | +$10.2K | ﹤0.01% | 420 |
|
|
2015
Q1 | $52K | Hold |
501
| – | – | ﹤0.01% | 432 |
|
|
2014
Q4 | $49K | Hold |
501
| – | – | ﹤0.01% | 361 |
|
|
2014
Q3 | $40K | Hold |
501
| – | – | ﹤0.01% | 361 |
|
|
2014
Q2 | $38K | Hold |
501
| – | – | ﹤0.01% | 391 |
|
|
2014
Q1 | $38K | Sell |
501
-100
| -17% | -$7.06K | ﹤0.01% | 363 |
|
|
2013
Q4 | $43K | Hold |
601
| – | – | ﹤0.01% | 355 |
|
|
2013
Q3 | $35K | Sell |
601
-1
| -0.2% | -$60 | ﹤0.01% | 351 |
|
|
2013
Q2 | $35K | Buy |
+602
| New | +$34.9K | 0.01% | 323 |
|
Other funds holding CVS
Transamerica Financial Advisors's CVS Position: Q2 2026 in Review
Transamerica Financial Advisors increased its CVS Health (CVS) stake by 53% in Q2 2026, buying an estimated $116K and bringing the position to 3,755 shares worth $388K. The position accounts for 0.03% of the portfolio, ranked #321.
Transamerica Financial Advisors first reported a position in CVS in Q2 2013 and has held it in 35 quarters since. The position peaked at $1.32M in Q2 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Transamerica Financial Advisors held 3,755 shares of CVS Health worth $388K as of Q2 2026.
- Transamerica Financial Advisors bought 1,295 CVS Health shares in Q2 2026, an estimated $116K.
- CVS Health made up 0.03% of Transamerica Financial Advisors's portfolio in Q2 2026, its #321 holding.
- Transamerica Financial Advisors first reported a position in CVS Health in Q2 2013 and has held it in 35 quarters since.
- Transamerica Financial Advisors's CVS Health position peaked at $1.32M in Q2 2023.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.